Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 7 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Specimen Handling 40 Magnetic Resonance Spectroscopy 30 Carboplatin 14 Biopsy 14 Radiation 13 Cyclophosphamide 13 Radiotherapy 11 daratumumab 10 Vincristine 10 Dexamethasone 10 Surgical Procedures, Operative 9 Etoposide 9 Lenalidomide 8 X-Rays 7 Observation 7 Leucovorin 7 Irinotecan 7 Doxorubicin 7 Cisplatin 7 durvalumab 6 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Watchful Waiting 6 Standard of Care 6 Radiosurgery 6 Practice Guidelines as Topic 6 Docetaxel 6 Calcium Dobesilate 6 pembrolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × mogamulizumab × Clear all

NCT04128072 2024-04-05

MOGAT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡